Key result
An educational program providing pharmaceutical guidance for 9 months resulted in a greater decrease in arterial pressure, tryacylglicerol, and waist-hip ratio compared to standard care.
Why the study?
The impact of an educational program including pharmaceutical guidance on hypertensive patients' adherence to treatment and clinical response was evaluated.
Does an educational program and pharmaceutical guidance improve clinical response and adherence in hypertensive patients?
Does an educational program and pharmaceutical guidance improve clinical response and adherence in hypertensive patients?
A 9-month educational program and pharmaceutical guidance improved blood pressure, lipid profiles, and disease knowledge in hypertensive patients.
Pharmaceutical education may improve BP control and adherence metrics in hypertension outpatients; leaves open need for larger randomized trials before practice change.
This study was carried out in the outpatient unit of the Teaching Hospital of the University of São Paulo (USP), and studied the impact of an educational program aimed at improving hypertensive patients' compliance to treatment. Seventy five (75) hypertensive patients of both sexes took part in the study which had no age or race discrimination. Participants presented no other concomitant pathology, except obesity, diabetes and dyslipidemia. Forty one patients were allocated to an experimental group (EG). Experimental patients attended lectures on the use of medication and artery hypertension (AH) and received personal pharmaceutical guidance for nine months. The control group (CG) comprised 34 patients who did not attend lectures or receive pharmaceutical advice in this period. The results were assessed by means of serum levels of cholesterol and fractions of tryacylglicerol (TG), urine sodium and potassium, arterial pressure (AP), body mass index (BMI), waist-hip ratio (WHR), and also based on responses to a questionnaire focusing on AH and treatment. Patients who received the guidance showed a greater decrease in AP, TG and WHR, besides an increase of potassium excretion through urine. The experimental group also scored higher on the questionnaires compared to the CG. It was concluded that the educational process, applied under the conditions of the present study, improves clients' clinical response to antihypertensive treatment and should be included in therapeutic strategies of health care services dealing with hypertensive patients.
No takes yet. Share an insight, caveat, or question.
Mori et al. (2010) studied Hypertension (n=75). Educational program and personal pharmaceutical guidance vs. No lectures or pharmaceutical advice was evaluated on Serum levels of cholesterol and tryacylglicerol, urine sodium and potassium, arterial pressure, body mass index, waist-hip ratio, and questionnaire responses. An educational program providing pharmaceutical guidance for 9 months resulted in a greater decrease in arterial pressure, tryacylglicerol, and waist-hip ratio compared to standard care.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: